NOCIL Limited (NSE:NOCIL)
168.13
-1.01 (-0.60%)
May 29, 2026, 3:29 PM IST
NOCIL Revenue
In the fiscal year ending March 31, 2026, NOCIL had annual revenue of 13.03B INR, down -6.44%. NOCIL had revenue of 3.30B in the quarter ending March 31, 2026, a decrease of -2.75%.
Revenue
13.03B
Revenue Growth
-6.44%
P/S Ratio
2.16
Revenue / Employee
17.68M
Employees
737
Market Cap
28.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 13.03B | -897.20M | -6.44% |
| Mar 31, 2025 | 13.93B | -519.80M | -3.60% |
| Mar 31, 2024 | 14.45B | -1.72B | -10.63% |
| Mar 31, 2023 | 16.17B | 452.60M | 2.88% |
| Mar 31, 2022 | 15.71B | 6.47B | 69.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 43.63B |
| Laxmi Organic Industries | 28.47B |
| Rossari Biotech | 23.96B |
| S H Kelkar and Company | 23.68B |
| Veedol Corporation | 21.69B |
| Jubilant Agri and Consumer Products | 18.04B |
| Advanced Enzyme Technologies | 7.81B |
| Jai Corp | 6.66B |
NOCIL News
- 2 months ago - NOCIL approves ₹130 crore investment for Dahej plant expansion - Business Upturn
- 7 months ago - NOCIL shares fall nearly 4% as Q2 profit drops 71% YoY; revenue declines 11.6% - Business Upturn
- 7 months ago - NOCIL Q2 results: Profit plunges 71% YoY to ₹12 crore as revenue and margins weaken - Business Upturn
- 1 year ago - NOCIL shares drop 5% as revenue falls 6.75% YoY to Rs 318 crore in Q3 - Business Upturn